Kinetics and isotype assessment of antibodies targeting the spike protein receptor‐binding domain of severe acute respiratory syndrome‐coronavirus‐2 in COVID‐19 …

NR Graham, AN Whitaker, CA Strother… - Clinical & …, 2020 - Wiley Online Library
Objectives There is an incomplete understanding of the host humoral immune response to
severe acute respiratory syndrome (SARS)‐coronavirus (CoV)‐2, which underlies COVID …

[PDF][PDF] COVID-19 and periodontal disease—Ethiopathogenic and clinical implications

MA Martu, GA Maftei, IG Sufaru, I Jelihovschi… - Rom. J. Oral Rehabil, 2020 - rjor.ro
SARS-CoV-2 was first discovered in December 2019 as the etiologic agent of a serious
respiratory illness later called COVID-19 or coronavirus disease 2019. The first COVID-19 …

Association between hypertension and prognosis of patients with COVID-19: A systematic review and meta-analysis

Z Qian, Z Li, J Peng, Q Gao, S Cai… - Clinical and Experimental …, 2022 - Taylor & Francis
Background To investigate the association between hypertension and clinical outcomes,
including in-hospital mortality, intensive care unit (ICU) admission, and invasive ventilation …

[PDF][PDF] COVID-19-Betroffenheit in der vollstationären Langzeitpflege

R Kohl, K Jürchott, C Hering, A Gangnus… - Pflege-Report 2021 …, 2021 - library.oapen.org
Die Corona-Pandemie deckt die Schwächen des stationären Pflegesystems–schon vor der
Pandemie waren diese abzusehen–nun schonungslos auf. Der vorliegende Beitrag …

[HTML][HTML] Managing noncommunicable diseases during the COVID-19 pandemic in Brazil: findings from the PAMPA cohort

JS Leite, N Feter, EL Caputo, IR Doring… - Ciência & Saúde …, 2021 - SciELO Public Health
The objective was to identify the impact of social distance in the management of
noncommunicable diseases (NCD) in the adult population from the state of Rio Grande do …

[HTML][HTML] Clustering of comorbidities

YV Chudasama, K Khunti, MJ Davies - Future Healthcare Journal, 2021 - ncbi.nlm.nih.gov
Within the last decade, clustering of comorbidities has become an increasing health problem
on a global scale and will continue to challenge healthcare professionals in the coming …

Impact of arterial hypertension and use of antihypertensive pharmacotherapy on mortality in patients hospitalized due to COVID-19: the CRACoV-HHS study

W Wojciechowska, M Terlecki, M Klocek, A Pac… - …, 2022 - Am Heart Assoc
Background: Cardiovascular diseases including arterial hypertension are common
comorbidities among patients hospitalized due to COVID-19. We assessed the influence of …

RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

A Di Castelnuovo, S Costanzo, A Antinori… - Vascular …, 2020 - Elsevier
Objective The hypothesis that been set forward that use of Renin Angiotensin Aldosterone
System (RAAS) inhibitors is associated with COVID− 19 severity. We set-up a multicenter …

[HTML][HTML] Comportamentos de proteção contra COVID-19 entre adultos e idosos brasileiros que vivem com multimorbidade: iniciativa ELSI-COVID-19

SR Batista, ASS Souza, J Nogueira… - Cadernos de Saúde …, 2020 - SciELO Brasil
Objetivou-se medir a ocorrência de comportamentos de proteção contra a COVID-19 e
fatores sociodemográficos segundo a ocorrência de multimorbidade na população …

Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19

F Angeli, J Marazzato, P Verdecchia… - European Journal of …, 2021 - Elsevier
Aims heart failure (HF) and coronary artery disease (CAD) are independent predictors of
death in patients with COVID-19. The adverse prognostic impact of the combination of HF …